Biotech

All Articles

ArsenalBio raises $325M, pivots far from former lead property

.Collection Biosciences is actually moving on up. The cell therapy company has actually added on $32...

Lilly- supported fat burning biotech documents IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually f...

Aelis' cannabis use medication fails stage 2b, driving Indivior to reassess $100M alternative

.Aelis Farma's hopes of safeguarding a quick, beneficial selection on a $100 million choice remittan...

ProKidney halts stage 3 test certainly not needed for cell treatment approval

.ProKidney has ceased one of a pair of phase 3 tests for its cell treatment for kidney disease after...

Vaxcyte rises on 'sensational' 31-valent PCV win against Pfizer

.Vaxcyte revealed what analysts called "sensational" stage 1/2 data for its own 31-valent pneumococc...

Recursion's mind condition test reveals little evidence of efficacy

.Recursion has actually discovered with an early examination of its own tech-enabled strategy to med...

Acepodia, Pfizer click all together for chemistry-based tissue treatment

.Contact it an instance of excellent chemical make up: Acepodia, a biotech based upon Nobel Prize-wi...

Praxis epilepsy drug decreases confiscations in stage 2 litigation

.Practice Preciseness Medicines has scored another midphase win in epilepsy this year, with its salt...

Three directors resign as Dyne messages mixed information for DMD prospect

.After running away a professional grip many years back, Dyne Therapeutics has shown brand-new perio...

Arrowhead fires off phase 3 information in rare metabolic condition in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its give in front of a possible showdown along with Io...